These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 5322748)

  • 41. Glucose tolerance in diabetes mellitus during treatment with the sulfonylurea hypoglycemic agents.
    Herman JB
    Isr J Med Sci; 1966; 2(6):733-7. PubMed ID: 5956689
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of hypoglycemic agents on liver regeneration.
    Gershbein LL
    Biochem Pharmacol; 1967 Jun; 16(6):1117-20. PubMed ID: 6040393
    [No Abstract]   [Full Text] [Related]  

  • 43. Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide.
    Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1980 Apr; 17(4):285-93. PubMed ID: 6995130
    [No Abstract]   [Full Text] [Related]  

  • 44. Long-term experience with sulfonylureas and placebo.
    Singer DL; Hurwitz D
    N Engl J Med; 1967 Aug; 277(9):450-6. PubMed ID: 5340346
    [No Abstract]   [Full Text] [Related]  

  • 45. [Action of tolbutamide and insulin on the disappearance curve of hyperglycemia provoked by intravenous administration of glucose].
    Di Perri T; Gennari C; Lusini C
    Atti Accad Fisiocrit Siena Med Fis; 1964; 13(1):255-62. PubMed ID: 5839963
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of tolbutamide on the electrocardiogram].
    Simícek J; Reil P
    Cas Lek Cesk; 1968; 107(41):1240-2. PubMed ID: 5680310
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical evaluation of a new oral antidiabetic--acetohexamide (Dymelor)].
    dos Anjos MN; do Valle JP
    Hospital (Rio J); 1965 Aug; 68(2):381-7. PubMed ID: 5322655
    [No Abstract]   [Full Text] [Related]  

  • 48. Preliminary report on the hypoglycaemic effect of Trifolium alexandrinum and Lupinus termis in animal and man.
    Helmi R; el-Mahdy SA; Ali H; Khayyal MA
    J Egypt Med Assoc; 1969; 52(7):538-51. PubMed ID: 5365916
    [No Abstract]   [Full Text] [Related]  

  • 49. Mode of action of oral hypoglycaemic agents. II. Sulphonylureas & biguanides in rats.
    Augusti KT; Kurup PA
    Indian J Biochem; 1969 Mar; 6(1):36-9. PubMed ID: 4332123
    [No Abstract]   [Full Text] [Related]  

  • 50. Potentiation of acetohexamide hypoglycemia by phenylbutazone.
    Field JB; Ohta M; Boyle C; Remer A
    N Engl J Med; 1967 Oct; 277(17):889-94. PubMed ID: 6061822
    [No Abstract]   [Full Text] [Related]  

  • 51. Attempts to delay the progression of chemical diabetes.
    Jimenez JA; Oppermann W; De Lellis RH; Camerini-Dávalos RA
    Adv Metab Disord; 1970; 1():Suppl 1:421+. PubMed ID: 5446909
    [No Abstract]   [Full Text] [Related]  

  • 52. [Glibenclamide in the treatment of diabetes].
    Rojszykowa E
    Pol Tyg Lek; 1971 Jan; 26(4):149-52. PubMed ID: 5547508
    [No Abstract]   [Full Text] [Related]  

  • 53. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 54. Homeostasis of body weight in a diabetes clinic population.
    Goodner CJ; Ogilvie JT
    Diabetes; 1974 Apr; 23(4):318-26. PubMed ID: 4207366
    [No Abstract]   [Full Text] [Related]  

  • 55. Antidiuretic action of chlorpropamide and tolbutamide.
    Luethi A; Studer H
    Minn Med; 1969 Jan; 52(1):33-6. PubMed ID: 5762357
    [No Abstract]   [Full Text] [Related]  

  • 56. [The dynamics of insulinemia in man after administration of tolbutamide].
    Lenti G; Pellegrini A; Pagano G; Mascia V; Cirillo R
    Minerva Med; 1968 Feb; 59(10):479-87. PubMed ID: 5642230
    [No Abstract]   [Full Text] [Related]  

  • 57. Combinations of oral hypoglycemic drugs in obese, insulin-resistant diabetics.
    Fineberg SK
    Geriatrics; 1968 Sep; 23(9):137-46. PubMed ID: 5673663
    [No Abstract]   [Full Text] [Related]  

  • 58. ACETOHEXAMIDE: CLINICAL EVALUATION OF A NEW ORAL ANTIDIABETIC AGENT.
    ALTERMAN SL; LIEBER AL
    Curr Ther Res Clin Exp; 1964 Mar; 6():148-55. PubMed ID: 14131413
    [No Abstract]   [Full Text] [Related]  

  • 59. Behaviour of the IRI plasmatic level in diabetic subjects after intravenous injection of tolbutamide.
    Artenisio AC; Albanese MC; Allegra V; Sprovieri M; Alibrando S; Ragonese F; Corsi V
    Folia Endocrinol; 1974 Oct; 27(5):439-62. PubMed ID: 4480627
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
    Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.